外基因组抑制改善了对小细胞肺癌第一线治疗的反应
Nesrin Irep1, Kubilay Inci1, Pervin Elvan Tokgun2
1Department of Cancer Molecular Biology, Institution of Health Sciences, Pamukkale University, Denizli, Turkey.
Journal of cellular and molecular medicine
|February 14, 2024
概括
用GW4869或Nexinhib20抑制外体分泌增强了小细胞肺癌 (SCLC) 的化疗效果. 这种组合减少了癌细胞的增殖,并诱导了细胞亡,提供了新的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
- 药物发现 药物发现
背景情况:
- 外基因组调解细胞间的通信,并与致癌症产生有关.
- 目前用于小细胞肺癌 (SCLC) 的治疗方法存在局限性,并且没有针对外体分泌物的药物被批准用于人类.
研究的目的:
- 为了研究GW4869和Nexinhib20的疗效,外基因组抑制剂,与SCLC的化疗结合使用.
- 探索外体抑制对SCLC细胞增殖,细胞亡和关键蛋白质表达的影响.
主要方法:
- 用GW4869和Nexinhib20单独或与西斯普拉丁/埃托化物结合治疗SCLC细胞系.
- 对RAB27A,nSMase2,CD9,CD63,TSG101,p53,p21,Bax,BCL2,caspase-3和caspase-9的表达进行了分析.
- 细胞增殖和细胞亡的评估.
主要成果:
- GW4869和Nexinhib20有效抑制了RAB27A和nSMase2,减少了CD9,CD63和TSG101的表达.
- 组合疗法显著增强了西斯/埃托对SCLC细胞的抗癌作用.
- 外基因组抑制减少了增殖,诱导了亡,并调节了参与细胞死亡途径的关键蛋白质 (p53,p21,Bax,BCL2,caspases).
结论:
- 通过GW4869或Nexinhib20抑制外体分泌是一种有前途的策略,可以提高SCLC的化疗疗效.
- 组合的外体抑制和化疗表明对减少SCLC的增殖和诱导亡产生协同效应.
- 准外体通路为治疗小细胞肺癌提供了一种新的治疗途径.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
14.8K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
